12 Reksa Dana Terbaik dengan 512 / Grand Pharmaceutical Group Limited (SEHK)

Grand Pharmaceutical Group Limited

HK ˙ SEHK ˙ BMG210A71016

HK$ 8.98 ↑0.18 (2.05%)

2025-09-05
BAHAGING PRESYO

12 Reksa Dana Terbaik dengan HK:512 / Grand Pharmaceutical Group Limited

Halaman ini menampilkan semua reksa dana yang telah melaporkan posisi di HK:512 / Grand Pharmaceutical Group Limited. Baris berwarna hijau menunjukkan posisi baru. Klik tautan ikon untuk melihat riwayat transaksi selengkapnya.

Tingkatkan ke versi premium untuk membuka data premium dan ekspor ke Excel. .

Tanggal File	Sumber	Investor		Ketik	Presyo ng Avg (Silangan)	Saham	Δ Saham (%)	Dilaporkan Nilai ($1000)	Nilai Δ (%)	Alokasi Port (%)
2025-06-30	NP	VEIEX - Vanguard Emerging Markets Stock Index Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				17,207,210	0.94	13,186	42.62
2025-06-30	NP	VGTSX - Vanguard Total International Stock Index Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				20,434,403	6.48	15,659	50.44
2025-07-28	NP	AVEEX - Avantis Emerging Markets Equity Fund Institutional Class This fund is a listed as child fund of American Century Companies Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				271,500	0.00	298	70.29
2025-06-26	NP	FTIHX - Fidelity Total International Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				678,539	1.42	521	43.92
2025-04-28	NP	GBFFX - GMO Benchmark-Free Fund Class III				0	-100.00	0	-100.00
2025-04-28	NP	GIMFX - GMO Implementation Fund				0	-100.00	0	-100.00
2025-06-30	NP	VFSNX - Vanguard FTSE All-World ex-US Small-Cap Index Fund Institutional Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				4,157,240	-12.25	3,186	23.98
2025-06-26	NP	DFCEX - Emerging Markets Core Equity Portfolio - Institutional Class This fund is a listed as child fund of Dimensional Fund Advisors Lp and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				10,364,500	0.00	7,942	41.29
2025-08-28	NP	SSGVX - State Street Global Equity ex-U.S. Index Portfolio State Street Global All Cap Equity ex-U.S. Index Portfolio This fund is a listed as child fund of State Street Corp and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				574,500	341.92	638	531.68
2025-07-29	NP	GMEMX - GMO Emerging Markets Fund Class II				177,500		195
2025-06-24	NP	SFILX - Schwab Fundamental International Small Company Index Fund Institutional Shares This fund is a listed as child fund of Charles Schwab Investment Management Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				268,000	32.67	205	88.07
2025-06-26	NP	LSVZX - LSV Emerging Markets Equity Fund Institutional Class Shares				400,000	0.00	307	41.67

Other Listings

DE:MX6A

€ 0.96

Fintel data has been cited in the following publications:

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.